Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Phase II Clinical Trials of DCVAC Show Significant Benefit for Patients with Ovarian and Lung Cancer

b3cnewswire.June 04, 2018

Tag: clinical trials , DCVAC , Significant Benefit

PharmaSources Customer Service